Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The T helper 17 (Th17) cell pathway is a critical component of the adaptive immune system, playing a role in host defense and tissue inflammation. Th17 cells are characterized by the production of IL-17 family cytokines and their involvement in autoimmune and inflammatory diseases. Inhibition of the Th17 cell pathway aims to suppress the differentiation, function, or survival of these cells, often targeting key cytokines (IL-6, TGFβ), transcription factors (RORγt), or effector cytokines (IL-17A).
Inhibition of Th17 cell differentiation, function, or survival through targeting of key signaling molecules, transcription factors, or effector cytokines.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T helper 17 cell pathway (Th17 pathway).